Janus Living (JAN) has drawn attention after completing a $464 million follow on equity offering of 16,000,000 Class A-1 common shares priced at $29, structured through an income trust. See our latest analysis for Janus Living. Over the past few months Janus Living has seen building momentum, with a 90 day share price return of 15.15% and a year to date share price return of 29.79%, as the follow on equity deal and recent earnings update kept attention on the stock around its latest close of...

FFO jumped 40% on acquisitions and occupancy gains across senior housing portfolio.

JAN (NYSE:JAN) reported higher second-quarter revenue, adjusted EBITDA and funds from operations as the senior housing real estate investment trust benefited from organic growth and acquisitions completed during the first half of 2026. Janus Living said consolidated revenue increased 45% year over

Healthpeak Properties (NYSE:DOC) reported second-quarter adjusted funds from operations of $0.46 per share and raised its full-year adjusted FFO guidance by $0.02 to a range of $1.73 to $1.77 per share, citing improved same-store net operating income expectations in its lab and senior housing busine

Healthpeak Properties Inc (DOC) reports solid Q2 2026 results with raised FFO guidance, driven by strong senior housing growth and improved lab occupancy.

DOC is set to report Q2 results, with higher revenues expected as lab demand and senior care trends face pressure from interest expense.